Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis

被引:40
作者
Bártfai, Z
Gaede, KI
Russell, KA
Muraközy, G
Müller-Quernheim, J
Specks, U
机构
[1] Mayo Clin & Mayo Fdn, Div Pulm & Crit Care Med, Thorac Dis Res Unit, Rochester, MN 55905 USA
[2] Hosp Med, Res Ctr Borstel, D-23845 Borstel, Germany
[3] Semmelweis Univ, Sch Med, Dept Resp Med, Budapest, Hungary
关键词
ANCA; systemic vasculitis; Wegener's granulomatosis; microscopic polyangiitis; gene polymorphism; interleukin-10; transforming growth factor-beta(1)1; gender risk;
D O I
10.1016/S1521-6616(03)00211-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA) are systemic small vessel vasculitides associated with ANCA (AAV). Predominant Th1 and Th2 cytokine patterns have been reported for WG and MPA, respectively. Consequently, genotypes suppressing Th1 responses or augmenting Th2 responses may be more frequent in MPA than in WG. Transforming growth beta(1) (TGF-beta1) and interleukin-10 (IL-10) genes may modify the course of vasculitis. Therefore, we investigated associations between genotype frequencies of functional polymorphisms of these cytokine genes and clinical manifestations in AAV. One hundred sixty-one AAV patients and 153 healthy blood donors were genotyped for the biallelic polymorphism in codon 25 of the TGF-beta(1) gene and the biallelic polymorphism at position -1082 of the IL-10 gene. No difference was found for TGF-beta(1) codon 25 polymorphism between control and patient groups. In contrast, a significant shift toward the homozygous AA genotype of the IL-10 (-1082) polymorphism was found in WG (25%, p < 0.005) and MPA patients (39%; p < 0.00001) compared to controls (10.5%). Furthermore, in MPA the AA homozygous genotype was significantly more frequent in females (62.5%) compared to males (20%, p < 0.05). A contribution of the TGF-beta(1) codon 25 polymorphism to the susceptibility-defining genetic backgrounds of AAV appears unlikely. In contrast, our findings suggest a role of the enhanced IL-10 (-1082) PM in WG and MPA with a significant gender difference in MPA. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:330 / 337
页数:8
相关论文
共 74 条
  • [1] TRANSFORMING GROWTH-FACTOR-BETA AS A PREDICTOR OF LIVER AND LUNG FIBROSIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED BREAST-CANCER
    ANSCHER, MS
    PETERS, WP
    REISENBICHLER, H
    PETROS, WP
    JIRTLE, RL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) : 1592 - 1598
  • [2] Genotypic variation in the transforming growth factor-β1 gene -: Association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation
    Awad, MR
    El-Gamel, A
    Hasleton, P
    Turner, DM
    Sinnott, PJ
    Hutchinson, IV
    [J]. TRANSPLANTATION, 1998, 66 (08) : 1014 - 1020
  • [3] Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis
    Balding, CEJ
    Howie, AJ
    Drake-Lee, AB
    Savage, COS
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 125 (02) : 332 - 339
  • [4] BALLIEUX BEPB, 1995, CLIN EXP IMMUNOL, V100, P186
  • [5] MOLECULAR CONTROL OF B-LYMPHOCYTE GROWTH AND DIFFERENTIATION
    BANCHEREAU, J
    BRIERE, F
    LIU, YJ
    ROUSSET, F
    [J]. STEM CELLS, 1994, 12 (03) : 278 - 288
  • [6] Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure - The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study
    Cambien, F
    Ricard, S
    Troesch, A
    Mallet, C
    Generenaz, L
    Evans, A
    Arveiler, D
    Luc, G
    Ruidavets, JB
    Poirier, O
    [J]. HYPERTENSION, 1996, 28 (05) : 881 - 887
  • [7] Cantagrel A, 1999, ARTHRITIS RHEUM, V42, P1093, DOI 10.1002/1529-0131(199906)42:6<1093::AID-ANR5>3.0.CO
  • [8] 2-P
  • [9] LIMITED FORMS OF ANGIITIS AND GRANULOMATOSIS OF WEGENERS TYPE
    CARRINGTON, CB
    LIEBOW, AA
    [J]. AMERICAN JOURNAL OF MEDICINE, 1966, 41 (04) : 497 - +
  • [10] Csernok E, 1999, ARTHRITIS RHEUM, V42, P742, DOI 10.1002/1529-0131(199904)42:4<742::AID-ANR18>3.3.CO